ATE453865T1 - An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung - Google Patents

An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung

Info

Publication number
ATE453865T1
ATE453865T1 AT04730260T AT04730260T ATE453865T1 AT E453865 T1 ATE453865 T1 AT E453865T1 AT 04730260 T AT04730260 T AT 04730260T AT 04730260 T AT04730260 T AT 04730260T AT E453865 T1 ATE453865 T1 AT E453865T1
Authority
AT
Austria
Prior art keywords
derivatized
protected
nalpha
epsilone
fac
Prior art date
Application number
AT04730260T
Other languages
English (en)
Inventor
Roger Alberto
Jaw Pak
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Zuerich filed Critical Univ Zuerich
Application granted granted Critical
Publication of ATE453865T1 publication Critical patent/ATE453865T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/083—Neurotensin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT04730260T 2003-04-29 2004-04-29 An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung ATE453865T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03076252 2003-04-29
PCT/EP2004/004683 WO2004097406A2 (en) 2003-04-29 2004-04-29 Nϵ AND/OR Nα DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH [M(OH2)3(CO)3]+ BY FAC COORDINATION

Publications (1)

Publication Number Publication Date
ATE453865T1 true ATE453865T1 (de) 2010-01-15

Family

ID=33395905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730260T ATE453865T1 (de) 2003-04-29 2004-04-29 An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung

Country Status (11)

Country Link
US (1) US8512675B2 (de)
EP (1) EP1618380B1 (de)
JP (1) JP4866233B2 (de)
KR (1) KR20060003064A (de)
CN (1) CN100507563C (de)
AT (1) ATE453865T1 (de)
AU (1) AU2004235488A1 (de)
BR (1) BRPI0409906A (de)
CA (1) CA2524222C (de)
DE (1) DE602004024879D1 (de)
WO (1) WO2004097406A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2196222B1 (de) * 2003-10-20 2014-04-23 Universität Zürich Tricarbonylkomplexe des Rheniums beinhaltend einen zweizähnigen Aminosäure-Ligand und deren Anwendung als radiotherapeutisch chemotoxische Agentien.
WO2007147482A1 (en) * 2006-06-20 2007-12-27 Paul Scherrer Institut Triazole containing metal chelating agents
EP2146995A1 (de) * 2007-04-11 2010-01-27 Merck Eprova AG Folatkonjugate und entsprechende metall-chelat-komplexe zur verwendung bei der diagnostischen bilddarstellung und radiotherapie
KR101383655B1 (ko) * 2010-05-24 2014-04-10 주식회사 바이오이미징코리아 트리카르보닐 테크네슘-99ｍ 또는 레늄-188 표지 고리 알지디 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 신생혈관 관련 질환의 진단 또는 치료용 약학적 조성물
US11257630B2 (en) 2013-07-06 2022-02-22 Blue Horizons Innovations, Llc Primary nanoparticle fabrication

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007430A1 (en) * 1989-11-15 1991-05-30 The Upjohn Company Peptides containing cyclic tripeptides
NZ238688A (en) * 1990-06-28 1992-05-26 Smithkline Beecham Corp Substituted histidines: pharmaceutical compositions, preparation and uses thereof
US5571792A (en) * 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
AU1529997A (en) * 1996-01-16 1997-08-11 Warner-Lambert Company Substituted histidine inhibitors of protein farnesyltransferase
EP0879606A1 (de) * 1997-04-25 1998-11-25 Paul Scherrer Institut Verfahren zur Herstellung von facial Metall Tricarbonyl Verbindungen und ihre Anwendung zur Markierung von Biosubstraten
US6344178B1 (en) * 1997-04-25 2002-02-05 Mallinckrodt Inc. Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
US5824803A (en) * 1997-09-30 1998-10-20 The United States Of America As Represented By The Secretary Of The Navy Compounds labeled with cyanate or thiocyanate metal complexes for detection by infrared spectroscopy
US6844425B1 (en) * 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
US6926883B1 (en) * 1999-06-29 2005-08-09 Mallinckrodt Inc Group (VII) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
AU6488900A (en) 1999-06-29 2001-01-31 Mallinckrodt, Inc. Group (vii) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
ATE447557T1 (de) * 2000-08-17 2009-11-15 Pfizer Ltd Substitutuierte imidazole als tafia inhibitoren
CN1143864C (zh) * 2001-06-28 2004-03-31 中国人民解放军军事医学科学院基础医学研究所 肿瘤坏死因子－α受体的亲和肽及其应用

Also Published As

Publication number Publication date
JP2006527167A (ja) 2006-11-30
CN1781021A (zh) 2006-05-31
EP1618380B1 (de) 2009-12-30
WO2004097406A3 (en) 2005-05-19
DE602004024879D1 (de) 2010-02-11
EP1618380A2 (de) 2006-01-25
AU2004235488A1 (en) 2004-11-11
JP4866233B2 (ja) 2012-02-01
KR20060003064A (ko) 2006-01-09
US20070077195A1 (en) 2007-04-05
WO2004097406A2 (en) 2004-11-11
BRPI0409906A (pt) 2006-04-25
CA2524222A1 (en) 2004-11-11
CA2524222C (en) 2012-02-07
CN100507563C (zh) 2009-07-01
US8512675B2 (en) 2013-08-20

Similar Documents

Publication Publication Date Title
IT1209850B (it) Metodo per modificare in superficie polimeri e composizioni polimeriche impiegando metalli materiali nonmetallici e gas
AR247751A1 (es) Hidrato absorbente, articulo absorbente que lo comprende y metodo para inmovilizar un polimero absorbente en particulas
DE59305106D1 (de) Vorrichtung zur Herstellung von feinteiliger Metall- und Keramikpulver
ATE453865T1 (de) An einem biomolekül gebundenen n epsilon- und/oder n alpha derivatisiertem und organisch- geschütztem l-histidin zur hoch-effizienter markierung mit (m(h2o)3(co)3)+ mittels fac koordinierung
SE0302216D0 (sv) Indikeringsanordning
IT1085289B (it) Processo per la deposizione elettrolitica di metalli su materiali di zirconio
IT1051592B (it) Processo per la riduzione gassosa di materiali metallici
ATE482118T1 (de) Verfahren und vorrichtung zur vorhersage eines falls einer person aus einem fahrzeug oder dergleichen
ATE446579T1 (de) Behälter und verfahren zur gasdichten kapselung eines radioaktiven gegenstandes
DE58900637D1 (de) Verwendung von substituierten thioharnstoffen zur abtrennung komplex gebundener schwermetallionen.
DE68920557D1 (de) Vorrichtung zur Analyse der Zusammensetzung von Metallteilchen.
DE69123990D1 (de) Gerät zur Messung der Grössenverteilung von beugenden/streuenden Teilchen
IT1032346B (it) Complessi metalliferi utilizzabili come stabilizzatori di materiali organici e loro preparazione
DE60313345D1 (de) Vorrichtung zur drehsicherung von dosenenden in einem downstacker und entsprechendes verfahren
DE502006008037D1 (de) Vorrichtung zur durchführung einer anwendung
CH467872A (de) Verwendung eines legierten Stahls als Werkstoff zur Herstellung von diffusionschromierten Gegenständen
CH478591A (de) Verfahren und Vorrichtung zur Bildung von Granulat aus pulverförmigen, wasserfreien Stoffen
AT343874B (de) Vorgefertigtes bauelement zur erstellung und/oder erganzung von bauwerken sowie einer anordnung solcher bauelemente
DE50200928D1 (de) Zusatzstoff zur Verbesserung der bioenergetischen Eigenschaften anorganischer oder organischer Stoffe, insbesondere von mineralischen Baustoffen
ES145027U (es) Soporte prefabricado para la formacion de estuches.
MD1459Y (ro) Aplicarea compusului 1,10-fenantrolină în calitate de inhibitor al dezvoltării cancerului la viţă de vie
ATE50998T1 (de) Aluminium-zirkonium-metallorganische komplexe zur verwendung als kupplungs- und wasserabstossende verbindungen.
ATA52875A (de) Vorrichtung zur strahlenchemischen modifizierung von flachengebilden
PL127827U1 (pl) Konstrukcja wsporcza daszków osłaniających kosze do selektywnej segregacji odpadów na cztery frakcje, z koszami o kształcie brył geometrycznych, takich jak walec eliptyczny i/lub prostopadłościan o podstawie wpisanej w okrąg
DE1930036B2 (de) Einrichtung zur verhinderung des eindringens von fremdgasen am ausgang von gasanalysegeraeten od dgl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties